Hohimer Wealth Management LLC Reduces Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Share on StockTwits

Hohimer Wealth Management LLC decreased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,021 shares of the medical research company’s stock after selling 148 shares during the period. Hohimer Wealth Management LLC’s holdings in Thermo Fisher Scientific were worth $1,819,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in TMO. Norges Bank acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth $1,411,603,000. Capital World Investors boosted its holdings in shares of Thermo Fisher Scientific by 8.0% during the first quarter. Capital World Investors now owns 16,824,726 shares of the medical research company’s stock worth $4,771,494,000 after purchasing an additional 1,242,140 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Thermo Fisher Scientific by 55,392.1% during the first quarter. Fisher Asset Management LLC now owns 944,476 shares of the medical research company’s stock worth $267,853,000 after purchasing an additional 942,774 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of Thermo Fisher Scientific by 30.6% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,217,273 shares of the medical research company’s stock worth $628,819,000 after purchasing an additional 519,525 shares during the last quarter. Finally, Girard Partners LTD. boosted its holdings in shares of Thermo Fisher Scientific by 2,841.5% during the first quarter. Girard Partners LTD. now owns 528,475 shares of the medical research company’s stock worth $5,506,000 after purchasing an additional 510,509 shares during the last quarter. 87.51% of the stock is owned by institutional investors.

Shares of TMO traded up $8.53 during midday trading on Tuesday, reaching $387.46. 859,335 shares of the company were exchanged, compared to its average volume of 1,860,439. The stock has a 50-day moving average price of $355.28 and a 200-day moving average price of $328.87. The company has a market cap of $149.66 billion, a price-to-earnings ratio of 42.48, a P/E/G ratio of 2.40 and a beta of 1.04. Thermo Fisher Scientific Inc. has a 1-year low of $250.21 and a 1-year high of $395.00. The company has a current ratio of 2.32, a quick ratio of 1.69 and a debt-to-equity ratio of 0.67.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, April 22nd. The medical research company reported $2.94 EPS for the quarter, topping the Zacks’ consensus estimate of $2.79 by $0.15. The company had revenue of $6.23 billion for the quarter, compared to analysts’ expectations of $6.18 billion. Thermo Fisher Scientific had a return on equity of 17.25% and a net margin of 14.31%. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.81 earnings per share. Equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 12.73 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date of this dividend is Monday, September 14th. Thermo Fisher Scientific’s payout ratio is 7.13%.

TMO has been the topic of several analyst reports. Stifel Nicolaus decreased their price objective on Thermo Fisher Scientific from $345.00 to $315.00 and set a “buy” rating on the stock in a report on Thursday, April 2nd. SVB Leerink lifted their target price on Thermo Fisher Scientific from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, April 23rd. Needham & Company LLC lifted their target price on Thermo Fisher Scientific from $383.00 to $415.00 and gave the company a “buy” rating in a report on Tuesday, July 7th. Cowen reiterated a “buy” rating and issued a $380.00 target price on shares of Thermo Fisher Scientific in a report on Monday, July 6th. Finally, Wells Fargo & Co lifted their target price on Thermo Fisher Scientific from $300.00 to $340.00 and gave the company an “equal weight” rating in a report on Tuesday, April 21st. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $357.42.

In other news, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $348.00, for a total transaction of $870,000.00. Following the sale, the chief financial officer now directly owns 37,989 shares of the company’s stock, valued at $13,220,172. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Mark Stevenson sold 25,000 shares of Thermo Fisher Scientific stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $328.03, for a total value of $8,200,750.00. Following the sale, the chief operating officer now directly owns 73,538 shares in the company, valued at $24,122,670.14. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 97,500 shares of company stock worth $33,044,350. Corporate insiders own 0.44% of the company’s stock.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: What sectors are represented in the Nikkei Index?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.